Securities
Sep. 30, 2010
Biotech IPO Starts Small but Looks Up
Amyris Inc.'s initial public offering came in lower than anticipated, but the company's stock rose higher in its first full day of trading.
Daily Journal Staff Writer
Amyris Inc.'s initial public offering came in lower than anticipated, but the Emeryville company's stock rose higher on Tuesday, its first full day of trading - a positive sign in a tough market.
The $84.8 million IPO continued a recent trend in which investors are paying less than the target range for the initial shares of biotech firms. Where Amyris differed from many other ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In